ST Pharm rises 11.7% amid COVID-19 (Remdesivir) theme surge

On the 4th, the COVID-19 (Remdesivir) theme rose 3.06% compared to the previous day, showing strength, while ST Pharm, which is attracting attention as a related stock, surged 11.7% compared to the previous day. ST Pharm is known as a raw pharmaceutical materials specialist company.

[Graph] Major stock price changes in the COVID-19 (Remdesivir) theme

According to provisional data compiled at 10:16, institutions have been making large net purchases, buying 12,000 shares of ST Pharm.

[Table] Foreign and institutional net trading volume (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, ST Pharm's quant financial score is 6.99 points, ranking 3rd in the quant financial ranking within the COVID-19 (Remdesivir) related theme. This can be interpreted as ST Pharm having relatively low investment attractiveness from a financial perspective. On the other hand, BC World Pharm ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.